c-Src and EGFR Inhibition in Molecular Cancer Therapy: What Else Can We Improve?

The proto-oncogene c-Src is a non-receptor tyrosine kinase playing a key role in many cellular pathways, including cell survival, migration and proliferation. c-Src de-regulation has been observed in several cancer types, making it an appealing target for drug discovery efforts. Recent evidence emph...

Descripción completa

Detalles Bibliográficos
Autores principales: Belli, Stefania, Esposito, Daniela, Servetto, Alberto, Pesapane, Ada, Formisano, Luigi, Bianco, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352780/
https://www.ncbi.nlm.nih.gov/pubmed/32517369
http://dx.doi.org/10.3390/cancers12061489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352780/
https://www.ncbi.nlm.nih.gov/pubmed/32517369
http://dx.doi.org/10.3390/cancers12061489

Ejemplares similares